A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma

Ming Zhao, Michelle A. Rudek, Aleksandr Mnasakanyan, Carol Hartke, Roberto Pili, Sharyn D. Baker

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

A rapid, sensitive and selective method was developed and validated using LC/MS/MS for determination of MS-275 in human plasma. Sample preparation involved a single step liquid-liquid extraction by the addition of 0.2 ml of plasma with 5 ml acetonitrile/n-butyl-chloride. Separation of the compounds of interest, including the internal standard paclitaxel, was achieved on a Waters X-Terra™ C18 (50 mm × 2.1 mm i.d., 3.5 μm) analytical column using a mobile phase consisting of acetonitrile/ammonium acetate (pH 2.9; 2 mM)(60:40, v/v) containing 0.1% formic acid and isocratic flow at 0.15 ml/min for 3 min. The analytes were monitored by tandem-mass spectrometry with electrospray positive ionization. Linear calibration curves were generated over the range of 0.5-100 ng/ml with values for the coefficient of determination of >0.99. The values for both within day and between day precision and accuracy were well within the generally accepted criteria for analytical methods (<15%). This method was subsequently used to measure concentrations of MS-275 in cancer patients receiving an oral weekly dose of 4 mg/m2.

Original languageEnglish (US)
Pages (from-to)784-787
Number of pages4
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume43
Issue number2
DOIs
StatePublished - Jan 17 2007
Externally publishedYes

Fingerprint

Plasma (human)
formic acid
Liquid chromatography
Tandem Mass Spectrometry
Liquid Chromatography
Mass spectrometry
Assays
Liquids
Paclitaxel
Ionization
Liquid-Liquid Extraction
Calibration
Plasmas
Water
entinostat
acetonitrile
Neoplasms
butyl chloride
ammonium acetate

Keywords

  • LC/MS/MS
  • MS-275
  • Pharmacokinetics

ASJC Scopus subject areas

  • Analytical Chemistry
  • Pharmaceutical Science

Cite this

A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma. / Zhao, Ming; Rudek, Michelle A.; Mnasakanyan, Aleksandr; Hartke, Carol; Pili, Roberto; Baker, Sharyn D.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 43, No. 2, 17.01.2007, p. 784-787.

Research output: Contribution to journalArticle

Zhao, Ming ; Rudek, Michelle A. ; Mnasakanyan, Aleksandr ; Hartke, Carol ; Pili, Roberto ; Baker, Sharyn D. / A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma. In: Journal of Pharmaceutical and Biomedical Analysis. 2007 ; Vol. 43, No. 2. pp. 784-787.
@article{60fbb6ef86994fc29ffbb92c777f5cb8,
title = "A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma",
abstract = "A rapid, sensitive and selective method was developed and validated using LC/MS/MS for determination of MS-275 in human plasma. Sample preparation involved a single step liquid-liquid extraction by the addition of 0.2 ml of plasma with 5 ml acetonitrile/n-butyl-chloride. Separation of the compounds of interest, including the internal standard paclitaxel, was achieved on a Waters X-Terra™ C18 (50 mm × 2.1 mm i.d., 3.5 μm) analytical column using a mobile phase consisting of acetonitrile/ammonium acetate (pH 2.9; 2 mM)(60:40, v/v) containing 0.1{\%} formic acid and isocratic flow at 0.15 ml/min for 3 min. The analytes were monitored by tandem-mass spectrometry with electrospray positive ionization. Linear calibration curves were generated over the range of 0.5-100 ng/ml with values for the coefficient of determination of >0.99. The values for both within day and between day precision and accuracy were well within the generally accepted criteria for analytical methods (<15{\%}). This method was subsequently used to measure concentrations of MS-275 in cancer patients receiving an oral weekly dose of 4 mg/m2.",
keywords = "LC/MS/MS, MS-275, Pharmacokinetics",
author = "Ming Zhao and Rudek, {Michelle A.} and Aleksandr Mnasakanyan and Carol Hartke and Roberto Pili and Baker, {Sharyn D.}",
year = "2007",
month = "1",
day = "17",
doi = "10.1016/j.jpba.2006.08.006",
language = "English (US)",
volume = "43",
pages = "784--787",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma

AU - Zhao, Ming

AU - Rudek, Michelle A.

AU - Mnasakanyan, Aleksandr

AU - Hartke, Carol

AU - Pili, Roberto

AU - Baker, Sharyn D.

PY - 2007/1/17

Y1 - 2007/1/17

N2 - A rapid, sensitive and selective method was developed and validated using LC/MS/MS for determination of MS-275 in human plasma. Sample preparation involved a single step liquid-liquid extraction by the addition of 0.2 ml of plasma with 5 ml acetonitrile/n-butyl-chloride. Separation of the compounds of interest, including the internal standard paclitaxel, was achieved on a Waters X-Terra™ C18 (50 mm × 2.1 mm i.d., 3.5 μm) analytical column using a mobile phase consisting of acetonitrile/ammonium acetate (pH 2.9; 2 mM)(60:40, v/v) containing 0.1% formic acid and isocratic flow at 0.15 ml/min for 3 min. The analytes were monitored by tandem-mass spectrometry with electrospray positive ionization. Linear calibration curves were generated over the range of 0.5-100 ng/ml with values for the coefficient of determination of >0.99. The values for both within day and between day precision and accuracy were well within the generally accepted criteria for analytical methods (<15%). This method was subsequently used to measure concentrations of MS-275 in cancer patients receiving an oral weekly dose of 4 mg/m2.

AB - A rapid, sensitive and selective method was developed and validated using LC/MS/MS for determination of MS-275 in human plasma. Sample preparation involved a single step liquid-liquid extraction by the addition of 0.2 ml of plasma with 5 ml acetonitrile/n-butyl-chloride. Separation of the compounds of interest, including the internal standard paclitaxel, was achieved on a Waters X-Terra™ C18 (50 mm × 2.1 mm i.d., 3.5 μm) analytical column using a mobile phase consisting of acetonitrile/ammonium acetate (pH 2.9; 2 mM)(60:40, v/v) containing 0.1% formic acid and isocratic flow at 0.15 ml/min for 3 min. The analytes were monitored by tandem-mass spectrometry with electrospray positive ionization. Linear calibration curves were generated over the range of 0.5-100 ng/ml with values for the coefficient of determination of >0.99. The values for both within day and between day precision and accuracy were well within the generally accepted criteria for analytical methods (<15%). This method was subsequently used to measure concentrations of MS-275 in cancer patients receiving an oral weekly dose of 4 mg/m2.

KW - LC/MS/MS

KW - MS-275

KW - Pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=33845621660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845621660&partnerID=8YFLogxK

U2 - 10.1016/j.jpba.2006.08.006

DO - 10.1016/j.jpba.2006.08.006

M3 - Article

VL - 43

SP - 784

EP - 787

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

IS - 2

ER -